PharmQuest Utilizes Tufan's Technology Development Expertise To Meet Time-Critical Demands Of...
Business Editors/Medical Writers
SAN JOSE, Calif.--(BW HealthWire)--March 15, 2001
PharmQuest Corporation, the Biopharmaceutical eR&D Company, and Tufan, Inc., a leader in software product development, today announced a partnership to develop software solutions for the pharmaceutical
PharmQuest's unique technologies and services enable drug developers in the biotechnology and pharmaceutical industries to access, manage and streamline relevant decision-making information to improve the success rate and speed of drugs to market.
"PharmQuest's goal is to ensure the quality and timeliness of developing new lead molecules and biologics that are emerging from the post-genomic era," said Deepak Visweswaraiah, vice president of Engineering at PharmQuest. "This requires an enormous focus on the information generated and analyzed during the drug development phase. In partnering with Tufan, PharmQuest will make dramatic gains in providing the informatics solutions, knowledge bases, and the workflow framework to integrate this information. We are confident that this partnership will allow us to scale up our engineering organization."
Speaking of the partnership, Dr. Suhas Patil, CEO of Tufan Inc., said, "Tufan will leverage its software development expertise to enable PharmQuest to offer a comprehensive software solution that will help the Pharmaceutical industry to significantly accelerate the drug development process."
About Tufan
Tufan, Inc. is a software product development company serving the high tech industry. Founded in October 1999, and headquartered in Mountain View, Calif., Tufan has an offshore product development center in Mumbai, India, with a strong engineering background in state of the art software technology, product development methodologies and processes. Additional information about Tufan is available at http://www.tufan.com.
About PharmQuest
PharmQuest Corporation, founded in 1999, is at the forefront of eR&D, which seeks to accelerate drug development via web-enabled tools and software solutions. eR&D is gaining wide acceptance among pharma industry leaders through e-initiatives. In its first year of operation, PharmQuest has partnered with 3 of the 10 largest pharmaceutical companies to achieve its mission of revolutionizing drug product development in the post-genomic era. Additional information about PharmQuest is available at http://www.pharmquest.com.
In addition, make sure to read these articles:
- NeoPharm Opens New Cancer Research & Development Center; New Waukegan Facility...
- Biotech Firms Focus R&D Agenda on Products of High Therapeutic Importance, Including...
- UTFC Invests in Sandy-Based Zorch Software; Firm Provides Project Management Tools and...
- Former FDA Commissioner Goyan Invests inPharmQuest.com.
- PharmQuest.com Launches Unique Web Site to AssistBiotechnology and Pharmaceutical Drug...
- PharmQuest.com Announces Appointments to the AdvisoryBoard.
- Proliance Pharmaceuticals Inc. Offers Alternative tothe Drug Development Paradigm.
- Xerion Pharmaceuticals Appointed Anil Singhal, Ph.D., as Chief Drug Development Officer;...
- PharmQuest Corporation Appoints Jerome A. Halperin to its Board of Directors.
- IRE Strengthens Senior Management Team WithAppointment of New Engineering VP; George Heron...
- PharmQuest to Host the e-Development Track and Panel Session At the eyeforpharma West 2001...
- Company Profile for Praxis.
- Industry Veterans Join PharmQuest.com'sBoard.
- Aquasearch and Ancile Pharmaceuticals to Form Drug Development Collaboration.
- Instem and PharmQuest Launch submit(TM), Enabling Organizations to Become SEND Compliant...
Email
Digg It
del.icio.us
Related Resources
Business Resources
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
© COPYRIGHT 2001 Business Wire
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
AllBusiness.com, its parent company D&B, and its affiliates.
